Magazine Article | May 2, 2018

Cultivating An R&D Ecosystem: Thriving Through Collaboration

Source: Life Science Leader

By Jennifer Ringler, Contributing Writer

In January, Pfizer announced the creation of the Innovative Target Exploration Network (ITEN), what the company calls “a new, early-stage partnering model that enables collaborative relationships with select academic institutions and principal investigators around the world, to identify research projects that have the potential to deliver novel therapeutic targets and mechanisms of action to underpin future drug discovery in core areas of interest to Pfizer.” In effect, this is a model that flourishes on collaboration with academia and private investigators in the earliest stages of R&D — often even before preclinical work.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: